Expert Video - Can biomarker testing help identify clinical trial opportunities for me?
Biomarker testing can allow patients to be matched with specific clinical trials through the US National Institutes of Health, says Dr. Robert Winn, an expert on cancer treatment from Virginia Commonwealth University. These precision medicine treatments are not yet widely available, but biomarker testing can help patients identify the trials that may be most helpful for their specific non-small-cell lung cancer.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
This educational activity has been developed by
A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.